跳至主要内容
临床试验/CTRI/2023/03/050962
CTRI/2023/03/050962尚未招募3 期

Prevalence and physiotherapeutic management for musculoskeletal, Gait and Balance impairments in individuals with post-Covid-19 infection

Vijayshree Singh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Post covid-19 recovered patients.
  • Subjects who are willing to give written consent.
  • Participants with age group of 18-45years.
  • Gender both male and female.
  • Subjects with post Covid- 19 syndrome more than 12 weeks.
  • Patients with no pre-existing musculoskeletal problems.
  • Patients with no pre-existing deformity.
  • Arthralgia, joint pain.
  • Muscle weakness.
  • Fibromyalgia.
  • Joint stiffness.
  • Gait abnormality due to joint pain.
  • Reduced functional efficiency.
  • Patients on specific medication: calcium, Vit D and pain killers.

排除标准

  • Malignancy.
  • Amputation patients.
  • Any fracture prior to Covid-19.
  • Bed ridden patients.
  • Un-cooperative patients.
  • Subjects having metal implants.
  • Subjects having psychosomatic disorder.
  • Recent fractures.
  • Earlier arthritis.
  • Any neurological condition affecting gait and balance co-ordination.
  • Post Covid stroke patients.
  • Heart conditions/hypertension.
  • Chronic kidney disease/undergoing dialysis.
  • Liver disease.
  • Patients on any previous medications specifically on drugs like antipsychotic, anti-depressants, Immunosuppressive, multivitamins or any nutritional supplements.
  • Immunocompromised (HIV/SCID etc.).

研究者

发起方
Vijayshree Singh

相似试验